Gestational diabetes & diabetes in pregnancy
Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes
Authors' conclusion
CGM use was associated with improved maternal glucose levels in a diverse real-world cohort.
Study context
- Population
- T1D pregnancies at the Barbara Davis Center for Diabetes, 2014–2020; obstetric care at multiple practices (Colorado and Wyoming)T1D pregnancies
- Participants
- 160 pregnancies
- Exposure
- Continuous glucose monitoring (CGM) vs self-monitoring of blood glucose (SMBG)
- CGMn = 109
- SMBGn = 51reference
- Outcome
- Maternal glucose control and gestational health outcomes
Methodological detailsreal-world setting, single-centre, Data from electronic medical records, hospital records and vital statistics departments; Student's t-test and chi-square test
- Real-world setting
- Single-centre
- Data from electronic medical records, hospital records and vital statistics departments; Student's t-test and chi-square test
Main finding
As reported in the abstract
Meeting trimester-specific HbA1c goals · throughout pregnancy and postpartum
- More participants meeting trimester-specific hemoglobin A1C (HbA1c) goals in CGM group
- CGM vs SMBG: P < 0.01 in each time period
Observational data: associations, not effects.
Further findings
Macrosomia
P = 0.01
Neonatal ICU admission
P = 0.0989
- Never meeting HbA1c goals in any trimester · fewer with CGM
- P < 0.001
Other neonatal outcomes
- No significant differences in neonatal outcomes between groups, other than macrosomia
Original publication
Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes. Diabetes Technol Ther. Published 25 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →